An observational study in Varicose Veins of Lower Limb, Thromboses, Venous and Venous Insufficiency, sponsored by Russian Phlebological Association. Active, not recruiting at 1 site in Russia. Open to participants aged 10 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-29.
Sponsored by Russian Phlebological Association · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
A prospective study of individuals without varicose veins and who have primary varicose veins to assess the morbidity, risk factors and natural course of chronic lower limb vein disease.
Multicenter prospective cohort observational study based on a termless epidemiological registry. Periodic inspection and collection of data from the subjects is carried out annually, in the last quarter of the current year. Patient data is recorded in a digital database and is constantly updated
785 studies on the registry are indexed under Venous Thrombosis; 110 are open to participants now.
This study's planned enrollment of 100 is below the median of 301 across 274 observational studies indexed under Venous Thrombosis.
Browse Venous Thrombosis studies →Russian Phlebological Association is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
The main cohort is formed from those who do not have varicose veins, who are affected by different factors that we register (various physical activities, the presence or absence of pregnancy, etc.).
An additional cohort is formed from those who have varicose veins at the time of inclusion.
The goal is to track the natural evolution (progression) of the disease, to evaluate the incidence and risk factors of complications.
An extremely important criterion for the formation of the study population is the possibility to control the lower legs veins of observed individuals by a qualified vascular specialist. To date, a qualitative assessment of veins according to the CEAP classification is a weak point in longitudinal epidemiological studies.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Individuals who do not have varicose veins of lower legs: C0, C1 classes according to Clinical, Etiologic, Anatomic and Pathophysiologic classification (CEAP)
Individuals who have varicose veins of lower legs: C2 Ep class according to Clinical, Etiologic, Anatomic and Pathophysiologic classification (CEAP)
Incidence of primary varicose veins
Number of Participants with the first identified varicose veins (class C2 according to CEAP classification)
Time frame: 1 year
Progression of primary varicose veins
The presence of varicose veins in new areas of the lower extremites (each limb is divided into 8 areas: thigh - anterior, posterior, medial, lateral area; lower leg - anterior, posterior, medial, lateral area)
Time frame: 1 year
Incidence of chronic venous insufficiency
Number of participants with the first identified sign of chronic venous insufficiency (venous edema, venous eczema, hyperpigmentation of the skin, lipodermatosclerosis, venous ulcer)
Time frame: 1 year
Incidence of superficial vein thrombosis
Number of participants with first episode of superficial vein thrombosis
Time frame: 1 year
Incidence of reticular and telangiectatic leg veins
Number of Participants with the first identified eticular and telangiectatic leg veins ((class C1 according to CEAP classification)
Time frame: 1 year
Progression of reticular and telangiectatic leg veins
The presence of reticular and telangiectatic leg veins in new areas of the lower extremites (each limb is divided into 8 areas: thigh - anterior, posterior, medial, lateral area; lower leg - anterior, posterior, medial, lateral area)
Time frame: 1 year
Plan to share: No
Started Sep 2020 (actual). Primary completion is estimated for Sep 2030, 120 months after the start.
Of 103 non-industry observational studies under Venous Thrombosis, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 99. This study's planned 120 months is above that.
Counting every sponsor, half of 127 studies reached it within 46 months; a quarter within 21 and three quarters within 82.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Russian Phlebological Association